Regulation of NF-κB activity and inducible nitric oxide synthase by regulatory particle non-ATPase subunit 13 (Rpn13)

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 31, 2010, Pages 13854-13859

  Mazumdar, Tuhina ^a,c   Gorgun, F Murat ^a   Sha, Youbao ^a   Tyryshkin, Alexey ^a   Zeng, Shenyan ^a   Hartmann Petersen, Rasmus ^b   Jørgensen, Jakob Ploug ^b   Hendil, Klavs B ^b   Eissa, N Tony ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

Inflammation; Lung; Proteasome; Ubiquitin; UCH37

Indexed keywords

ENZYME; GLYCOPROTEIN; I KAPPA B KINASE ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; PROTEASOME; REGULATORY PARTICLE NON ATPASE SUBUNIT 13; UCH37 ENZYME; UNCLASSIFIED DRUG; ADHESION REGULATING MOLECULE 1, MOUSE; ADHESION-REGULATING MOLECULE 1, MOUSE; ADRM1 PROTEIN, HUMAN; CARBOXYPEPTIDASE; CELL ADHESION MOLECULE; MEMBRANE PROTEIN; NOS2 PROTEIN, MOUSE; NOS2A PROTEIN, HUMAN; SMALL INTERFERING RNA; UCHL5 PROTEIN, HUMAN;

ARTICLE; CELL LEVEL; CONTROLLED STUDY; GENE ACTIVATION; GENE ACTIVITY; GENE CONTROL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN INTERACTION; ANIMAL; CELL LINE; DOWN REGULATION; GENETICS; METABOLISM; MOUSE; PROTEIN BINDING;

ANIMALS; CARBOXYPEPTIDASES; CELL ADHESION MOLECULES; CELL LINE; DOWN-REGULATION; HUMANS; MEMBRANE GLYCOPROTEINS; MICE; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; PROTEIN BINDING; RNA, SMALL INTERFERING;

EID: 77956373713     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0913495107     Document Type: Article

References (27)

1. Goldberg AL (2003) Protein degradation and protection against misfolded or damaged proteins. Nature 426:895-899.
2. Hershko A, Ciechanover A (1998) The ubiquitin system. Annu Rev Biochem 67:425-479.
3. Finley D (2009) Recognition and processing of ubiquitin-protein conjugates by the proteasome. Annu Rev Biochem 78:477-513.
4. Verma R, et al. (2002) Role of Rpn11 metalloprotease in deubiquitination and degradation by the 26S proteasome. Science 298:611-615.
5. Yao T, Cohen RE (2002) A cryptic protease couples deubiquitination and degradation by the proteasome. Nature 419:403-407.
6. Koulich E, Li X, DeMartino GN (2008) Relative structural and functional roles of multiple deubiquitylating proteins associated with mammalian 26S proteasome. Mol Biol Cell 19:1072-1082.
7. Hamazaki J, et al. (2006) A novel proteasome interacting protein recruits the deubiquitinating enzyme UCH37 to 26S proteasomes. EMBO J 25:4524-4536.
8. Jørgensen JP, et al. (2006) Adrm1, a putative cell adhesion regulating protein, is a novel proteasome-associated factor. J Mol Biol 360:1043-1052.
9. Qiu XB, et al. (2006) hRpn13/ADRM1/GP110 is a novel proteasome subunit that binds the deubiquitinating enzyme, UCH37. EMBO J 25:5742-5753.
10. Yao T, et al. (2006) Proteasome recruitment and activation of the Uch37 deubiquitinating enzyme by Adrm1. Nat Cell Biol 8:994-1002.
11. Simins AB, Weighardt H, Weidner KM, Weidle UH, Holzmann B (1999) Functional cloning of ARM-1, an adhesion-regulating molecule upregulated in metastatic tumor cells. Clin Exp Metastasis 17:641-648.
12. Ratovitski EA, et al. (1999) An inducible nitric-oxide synthase (NOS)-associated protein inhibits NOS dimerization and activity. J Biol Chem 274:30250-30257.
13. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G (1987) Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 84:9265-9269.
14. Xie QW, et al. (1992) Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 256:225-228.
15. Husnjak K, et al. (2008) Proteasome subunit Rpn13 is a novel ubiquitin receptor. Nature 453:481-488.
16. Schreiner P, et al. (2008) Ubiquitin docking at the proteasome through a novel pleckstrin-homology domain interaction. Nature 453:548-552.
17. Marks-Konczalik J, Chu SC, Moss J (1998) Cytokine-mediated transcriptional induction of the human inducible nitric oxide synthase gene requires both activator protein 1 and nuclear factor kappaB-binding sites. J Biol Chem 273:22201-22208.
18. Xie QW, Kashiwabara Y, Nathan C (1994) Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J Biol Chem 269:4705-4708.
19. Karin M, Ben-Neriah Y (2000) Phosphorylation meets ubiquitination: The control of NF-[kappa]B activity. Annu Rev Immunol 18:621-663.
20. Mathes E, O'Dea EL, Hoffmann A, Ghosh G (2008) NF-kB dictates the degradation pathway of Ik-Bα. EMBO J 27:1357-1367.
21. Kolodziejski PJ, Musial A, Koo J-S, Eissa NT (2002) Ubiquitination of inducible nitric oxide synthase is required for its degradation. Proc Natl Acad Sci USA 99:12315-12320.
22. Musial A, Eissa NT (2001) Inducible nitric-oxide synthase is regulated by the proteasome degradation pathway. J Biol Chem 276:24268-24273.
23. Kolodziejski PJ, Koo J-S, Eissa NT (2004) Regulation of inducible nitric oxide synthase by rapid cellular turnover and cotranslational down-regulation by dimerization inhibitors. Proc Natl Acad Sci USA 101:18141-18146.
24. Tyryshkin A, et al. (2010) SRC kinase-mediated phosphorylation stabilizes inducible nitric-oxide synthase in normal and in cancer cells. J Biol Chem 285:784-792.
25. Gronostajski RM, Pardee AB, Goldberg AL (1985) The ATP dependence of the degradation of short- and long-lived proteins in growing fibroblasts. J Biol Chem 260:3344-3349.
26. Janse DM, Crosas B, Finley D, Church GM (2004) Localization to the proteasome is sufficient for degradation. J Biol Chem 279:21415-21420.
27. Eissa NT, et al. (1998) Cloning and characterization of human inducible nitric oxide synthase splice variants: A domain, encoded by exons 8 and 9, is critical for dimerization. Proc Natl Acad Sci USA 95:7625-7630.